926

    524372

    ORCHPHARMA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ORCHID PHARMA LIMITED Share Price Today

    ORCHID PHARMA LIMITED is currently trading at ₹1001.45, up by ₹16.1 from the previous close. The stock touched an intraday high of ₹1022.00 and a low of ₹982.10 during the latest trading session. Over the past one year, ORCHID PHARMA LIMITED has delivered a return of 40.77%, while the stock has gained 3.63% in the last one month.

    ORCHID PHARMA LIMITED performance

    Today’s low Today’s high
    ₹ 982.10 ₹ 1022.00
    ₹ 1001.45
    52 week low 52 week high
    ₹ 480.00 ₹ 1119.80
    ₹ 1001.45
    Open Price ₹ 982.10
    Prev. Close ₹ 985.35
    Volume (Shares) 47133.00
    Total traded value ₹ 472.01
    Upper Circuit ₹ 1182.40
    Lower Circuit ₹ 788.30
    info

    Investment Returns

    Over 1 Month 3.63% Over 3 Months 68.34% Over 6 Months 41.17% Over 1 Year 40.77%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ORCHID PHARMA LIMITED fundamentals


    • Market cap (Cr) 5,079.30
    • P/E Ratio (TTM) 110.62
    • Beta 1.07
    • Book Value / share 270.14
    • Return on equity 3.32%
    • EPS (TTM) 10.21
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 30.60
    info icon alternate text
    • Market cap (Cr) 5,080.30
    • P/E Ratio (TTM) 110.62
    • Beta 1.01
    • Book Value / share 270.14
    • Return on equity 3.32%
    • EPS (TTM) 10.21
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 30.60
    info icon alternate text

    ORCHID PHARMA LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 237.61
    Operating Expense 220.84
    Net Profit 30.60
    Net Profit Margin (%) 12.87
    Earnings Per Share (EPS) 6.03
    EBITDA 42.83
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 207.27
    Operating Expense 216.57
    Net Profit -5.82
    Net Profit Margin (%) -2.80
    Earnings Per Share (EPS) -1.15
    EBITDA 6.32
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 193.52
    Operating Expense 206.72
    Net Profit 2.23
    Net Profit Margin (%) 1.15
    Earnings Per Share (EPS) 0.44
    EBITDA 14.75
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 172.93
    Operating Expense 170.66
    Net Profit 18.20
    Net Profit Margin (%) 10.52
    Earnings Per Share (EPS) 3.59
    EBITDA 30.11
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 237.48
    Operating Expense 215.89
    Net Profit 27.85
    Net Profit Margin (%) 11.72
    Earnings Per Share (EPS) 5.49
    EBITDA 40.59
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 811.33
    Operating Expense 814.79
    Net Profit 45.21
    Net Profit Margin (%) 5.57
    Earnings Per Share (EPS) 8.91
    EBITDA 94.01
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 921.93
    Operating Expense 847.37
    Net Profit 106.48
    Net Profit Margin (%) 11.54
    Earnings Per Share (EPS) 20.99
    EBITDA 155.46
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 819.37
    Operating Expense 758.24
    Net Profit 94.75
    Net Profit Margin (%) 11.56
    Earnings Per Share (EPS) 19.59
    EBITDA 141.07
    Effective Tax Rate (%) -3.52
    Particulars MAR 2023 (Values in Cr)
    Revenue 665.90
    Operating Expense 669.30
    Net Profit 54.19
    Net Profit Margin (%) 8.13
    Earnings Per Share (EPS) 13.28
    EBITDA 142.26
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 556.97
    Operating Expense 618.75
    Net Profit -4.81
    Net Profit Margin (%) -0.86
    Earnings Per Share (EPS) -1.18
    EBITDA 66.25
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 236.35
    ROE % 2.86
    ROCE % 3.15
    Total Debt to Total Equity 0.13
    EBITDA Margin 15.73
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 217.06
    ROE % 3.02
    ROCE % 3.20
    Total Debt to Total Equity 0.25
    EBITDA Margin 17.32
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 151.92
    ROE % 0.29
    ROCE % 1.47
    Total Debt to Total Equity 0.45
    EBITDA Margin 15.46
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 141.81
    ROE % 0.06
    ROCE % -1.10
    Total Debt to Total Equity 0.55
    EBITDA Margin 11.27
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 143.16
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.72
    EBITDA Margin 9.91
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 247.54
    ROE % 3.32
    ROCE % 3.61
    Total Debt to Total Equity 0.12
    EBITDA Margin 16.90
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 226.69
    ROE % 3.15
    ROCE % 3.33
    Total Debt to Total Equity 0.24
    EBITDA Margin 17.26
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 162.53
    ROE % 0.81
    ROCE % 2.34
    Total Debt to Total Equity 0.43
    EBITDA Margin 15.46
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 149.30
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.53
    EBITDA Margin 12.06
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 150.13
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.69
    EBITDA Margin 14.26
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 179.63
    Total Assets 1687.91
    Total Liabilities 1687.91
    Total Equity 1267.28
    Share Outstanding 5
    Price to Book Ratio 3.14
    Return on Assets (%) 5.90
    Return on Capital (%) 6.91
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 266.56
    Total Assets 1553.87
    Total Liabilities 1553.87
    Total Equity 1169.46
    Share Outstanding 5
    Price to Book Ratio 4.61
    Return on Assets (%) 5.93
    Return on Capital (%) 7.07
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 30.62
    Total Assets 1225.20
    Total Liabilities 1225.20
    Total Equity 688.64
    Share Outstanding 4
    Price to Book Ratio 2.37
    Return on Assets (%) 3.78
    Return on Capital (%) 4.54
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 8.06
    Total Assets 1110.56
    Total Liabilities 1110.56
    Total Equity 647.37
    Share Outstanding 4
    Price to Book Ratio 1.90
    Return on Assets (%) -0.17
    Return on Capital (%) -0.21
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 19.91
    Total Assets 1237.25
    Total Liabilities 1237.25
    Total Equity 652.90
    Share Outstanding 4
    Price to Book Ratio 16.42
    Return on Assets (%) -9.41
    Return on Capital (%) -10.76
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 164.28
    Total Assets 1696.58
    Total Liabilities 1696.58
    Total Equity 1324.04
    Share Outstanding 5
    Price to Book Ratio 3.14
    Return on Assets (%) 6.27
    Return on Capital (%) 7.11
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 257.22
    Total Assets 1552.20
    Total Liabilities 1552.20
    Total Equity 1218.31
    Share Outstanding 5
    Price to Book Ratio 4.61
    Return on Assets (%) 6.10
    Return on Capital (%) 7.01
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 22.33
    Total Assets 1223.25
    Total Liabilities 1223.25
    Total Equity 731.96
    Share Outstanding 4
    Price to Book Ratio 2.37
    Return on Assets (%) 4.42
    Return on Capital (%) 5.1
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.20
    Total Assets 1094.18
    Total Liabilities 1094.18
    Total Equity 677.95
    Share Outstanding 4
    Price to Book Ratio 1.90
    Return on Assets (%) -0.43
    Return on Capital (%) -0.51
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 18.96
    Total Assets 1224.46
    Total Liabilities 1224.46
    Total Equity 681.33
    Share Outstanding 4
    Price to Book Ratio 16.42
    Return on Assets (%) -9.56
    Return on Capital (%) -10.33
    Particulars MAR 2025 (Values in Cr)
    Net Income 99.46
    Cash from Operations 20.15
    Cash from Investing -26.93
    Cash from Financing 25.22
    Net change in Cash 17.50
    Free Cash Flow 170.26
    Particulars MAR 2024 (Values in Cr)
    Net Income 89.04
    Cash from Operations 125.36
    Cash from Investing -312.02
    Cash from Financing 167.04
    Net change in Cash -18.99
    Free Cash Flow 190.17
    Particulars MAR 2023 (Values in Cr)
    Net Income 46.31
    Cash from Operations 18.63
    Cash from Investing -31.21
    Cash from Financing 31.16
    Net change in Cash 18.29
    Free Cash Flow 103.54
    Particulars MAR 2022 (Values in Cr)
    Net Income -1.95
    Cash from Operations 94.38
    Cash from Investing 112.93
    Cash from Financing -216.79
    Net change in Cash -11.38
    Free Cash Flow 108.78
    Particulars MAR 2021 (Values in Cr)
    Net Income -116.53
    Cash from Operations 18.66
    Cash from Investing 67.20
    Cash from Financing -164.98
    Net change in Cash -74.19
    Free Cash Flow 19.26
    Particulars MAR 2025 (Values in Cr)
    Net Income 106.48
    Cash from Operations 28.42
    Cash from Investing -37.34
    Cash from Financing 25.44
    Net change in Cash 15.57
    Free Cash Flow 96.96
    Particulars MAR 2024 (Values in Cr)
    Net Income 91.52
    Cash from Operations 129.99
    Cash from Investing -315.80
    Cash from Financing 167.06
    Net change in Cash -18.01
    Free Cash Flow 185.14
    Particulars MAR 2023 (Values in Cr)
    Net Income 54.18
    Cash from Operations 13.68
    Cash from Investing -26.69
    Cash from Financing 31.16
    Net change in Cash 17.85
    Free Cash Flow 98.24
    Particulars MAR 2022 (Values in Cr)
    Net Income -4.80
    Cash from Operations 91.47
    Cash from Investing 112.93
    Cash from Financing -216.79
    Net change in Cash -14.30
    Free Cash Flow 105.87
    Particulars MAR 2021 (Values in Cr)
    Net Income -117.15
    Cash from Operations 19.44
    Cash from Investing 67.20
    Cash from Financing -164.98
    Net change in Cash -73.42
    Free Cash Flow 20.04
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.06 12.89 1.50 238.02 23.12 38.85
    BLISS GVS PHARMA LTD. 450.40 36.21 4.00 4776.77 118.35 552.90
    CIPLA LTD 1444.65 32.61 3.38 116705.37 1165.55 1672.20
    FERMENTA BIOTECH LTD. 456.25 21.34 3.30 1342.79 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.06 21.72 4.00 238.02 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 511.40 22.92 3.99 1478.49 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8069.50 105.46 23.11 20173.75 7630.00 9850.00
    BLISS GVS PHARMA LTD. 450.40 48.69 4.13 4776.77 118.35 552.90

    ORCHID PHARMA LIMITED shareholding pattern

    Holding
    8.61%
    69.83%
    0.8%
    20.74%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    ORCHID PHARMA LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1001.45 1.63 redarrow
    red-green-graph indicator
    5 Bearish
    11 Bullish
    • 5 Days 992.70
    • 26 Days 983.20
    • 10 Days 1002.40
    • 50 Days 919.80
    • 12 Days 1003.30
    • 100 Days 833.60
    • 20 Days 995.70
    • 200 Days 806.50
    981.82 PIVOT
    First Support 971.63 First Resistance 995.53 Second Support 957.92 Second Resistance 1005.72 Third Support 947.73 Third Resistance 1019.43
    RSI 50.73 ADX 14.30 MACD 20.04 Williams % R -80.10 Commodity Channel Index (CCI) -50.55
    Date 2026-07-28 Week 31461.00 Same Day 20658.00 Month 62550.00
    1 Year 1.08 3 Year 0.94
    Over 1 Month
    3.63% down
    Over 1 Year
    40.77% down
    Over 3 Months
    68.34% down
    Over 3 Years
    20.05% down
    Over 6 Months
    41.17% down
    Over 5 Years
    15.67% down

    ORCHID PHARMA LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    13 Sep 2012 3.0 Final 15 Sep 2012 Equity shares
    19 Jul 2011 3.0 Final 21 Jul 2011 Equity shares
    12 Jul 2010 10.0 Final 14 Jul 2010 Equity shares
    17 Sep 2009 1.0 Final 19 Sep 2009 Equity shares
    18 Sep 2008 3.0 Final 20 Sep 2008 Equity shares
    12 Jul 2007 3.0 Final 15 Jul 2007 Equity shares
    30 May 2006 0.0 Final 01 Jun 2006 Equity shares
    13 Jul 2005 0.0 Interim 15 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    17 Sep 2005 15 Sep 2005 1:2
    Dividend date Dividend amount Dividend type Record date Instrument type
    13 Sep 2012 3.0 Final 15 Sep 2012 Equity shares
    19 Jul 2011 3.0 Final 21 Jul 2011 Equity shares
    12 Jul 2010 10.0 Final 14 Jul 2010 Equity shares
    17 Sep 2009 1.0 Final 19 Sep 2009 Equity shares
    18 Sep 2008 3.0 Final 20 Sep 2008 Equity shares
    12 Jul 2007 3.0 Final 15 Jul 2007 Equity shares
    30 May 2006 0.0 Final 01 Jun 2006 Equity shares
    13 Jul 2005 0.0 Interim 15 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    17 Sep 2005 15 Sep 2005 1:2

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Orchid Pharma Ltd?

    Answer Field

    Orchid Pharma Ltd share price is for NSE ₹ 1,001.45 & for BSE ₹ 998.00 as on Jul 29 2026 03:30 PM.

    What is the Market Cap of Orchid Pharma Ltd Share?

    Answer Field

    The market cap of Orchid Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 29 2026 03:30 PM.

    What is the 52 Week High and Low of Orchid Pharma Ltd?

    Answer Field

    The 52 Week High and Low of Orchid Pharma Ltd for NSE is ₹ 1,119.80 and ₹ 480.00 and for BSE is ₹ 1,120.00 and ₹ 471.30.

    What is 1 year return for Orchid Pharma Ltd?

    Answer Field

    The 1 year returns on the stock has been 40.77%.

    What is the P/E Ratio of Orchid Pharma Ltd Share?

    Answer Field

    As on Jul 29 2026 03:30 PM the price-to-earnings (PE) ratio for Orchid Pharma Ltd share is 110.62.

    What is the PB ratio of Orchid Pharma Ltd Share?

    Answer Field

    As on Jul 29 2026 03:30 PM, the price-to-book (PB) ratio for Orchid Pharma Ltd share is 270.14.

    How to Buy Orchid Pharma Ltd Share?

    Answer Field

    You can trade in Orchid Pharma Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Orchid Pharma Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Orchid Pharma Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Orchid Pharma Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |